医疗保险计划类型与癌症幸存者医疗保健获取,利用和负担能力的关联
Faraz I Jafri1, Vishal R Patel1, Jianhui Xu2
1Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA.
Cancers
|August 12, 2023
概括
医疗保险优势计划不会改善癌症幸存者获得医疗保健或急性护理的机会. 这些在医疗保险优势中的幸存者更有可能面临经济困难,支付医疗费用.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 在瘤学瘤学.
- 卫生经济学 卫生经济学
背景情况:
- 医疗保险优势 (MA) 服务于近一半的医疗保险受益者,包括越来越多的癌症幸存者.
- 药物管理对癌症幸存者获得医疗保健,结果和负担能力的影响尚不清楚.
研究的目的:
- 评估医疗保险优势入学是否与传统医疗保险相比,与癌症幸存者改善医疗保健准入,急性护理利用率和负担能力有关.
主要方法:
- 这是一项采用2019年国家卫生访谈调查数据的横截面研究.
- 分析包括65岁以上有癌症病史的医疗保险受益人,将MA注册人与传统的医疗保险注册人进行比较.
- 使用多变量后勤回归来评估计划类型和医疗保健指标之间的关联.
主要成果:
- 在MA和传统的医疗保险癌症幸存者群体之间,在医疗保健获取或急性护理利用方面没有发现显著差异.
- 在MA的癌症幸存者更有可能担心医疗费用 (34.3%对29.4%) 和有问题支付它们 (13.6%对11.1%).
- 在调整了人口统计,社会经济和临床因素后,这些发现仍然存在.
结论:
- 与传统的医疗保险相比,医疗保险优势似乎没有为癌症幸存者提供更好的医疗保健,负担能力或急性护理利用率.
- 患有癌症的MA受益者报告了增加的财务压力和支付医疗账单的困难.
- 这项研究表明,对于癌症幸存者来说,医疗保险计划可能没有更高的成本效益,并为有关Medicare Advantage在健康公平方面的作用的政策讨论提供了信息.
相关概念视频
01:21Cancer Survival Analysis
384
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
384
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:29Documentation in Long-Term and Home Healthcare Setting
922
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
922